The company entered a Securities Exchange Agreement with SecureKloud Technologies Ltd. to settle outstanding obligations. Healthcare Triangle will issue 2,828,167 shares of common stock to SecureKloud (or its nominee) in exchange for the cancellation of 1,600,000 shares of Series B Convertible Preferred Stock. The company amended its January 2026 Share Purchase Agreement for Teyame AI, adjusting consideration to $12 million in restricted common stock and 18,000 shares of a new Series C Convertible Preferred Stock. A management earnout of 5,000 shares of Preferred Stock was established for fiscal years 2026 and 2027, contingent on performance targets. The company filed a Certificate of Designation for 23,000 shares of Series C Convertible Preferred Stock.